Trial reportJournal of the International Society of Sports Nutrition2025
Caffeine's influence on vertical jump height: a real-life collegiate student-athlete approach.
Trial report in Journal of the International Society of Sports Nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Caffeine and human performance: from molecular mechanisms to exercise and recovery.Frontiers in physiology · 2026Review
- Effects of Caffeine on NFL Combine-Like Tests in Undergraduate Students.International journal of exercise science · 2026Article
- Impact of a Four-Week NCAA-Compliant Pre-Season Strength and Conditioning Program on Body Composition in NCAA Division II Women's Basketball.Journal of functional morphology and kinesiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCaffeine's ergogenic potential in vertical jumping remains contested, particularly at dosages compliant with collegiate athletic regulations. The NCAA enforces a caffeine urinary threshold equivalent to ~5 mg/kg body mass, yet evidence supporting its efficacy in enhancing explosive performance among trained athletes is inconsistent. This study examined whether acute caffeine ingestion at this threshold improves squat jump (SJ) and countermovement jump (CMJ) performance in NCAA Division II student-athletes, while exploring sex-specific responses and trial-to-trial variability.
methodsForty NCAA Division II athletes (18 females, 22 males; 21.3 ± 2.4 years) participated in a single-blind, randomized, crossover trial. Participants ingested 5 mg/kg caffeine or placebo, followed by SJ and CMJ testing on a force platform 60 minutes post-consumption. Three trials per jump type were retained to preserve intra-individual variance. Linear mixed-effects models (LMMs) assessed fixed effects of condition, sex, and trials, with random intercepts and slopes accounting for individual variability. A priori power analyses guided sample size determination, targeting sensitivity to detect small-to-medium effects (Cohen's f ≥ 0.2).
resultsCaffeine elicited trivial, non-significant differences in SJ (β = -0.24 cm,
conclusionsA 5 mg/kg caffeine dose, compliant with NCAA thresholds, did not enhance vertical jump performance in habituated collegiate athletes, challenging prior assertions of its universal ergogenicity for ballistic tasks. While sex differences in baseline performance persisted, caffeine did not modulate these disparities, implicating neuromuscular and anthropometric factors as primary determinants. The absence of ergogenic effects aligns with NCAA safety-focused policies but highlights the need for personalized dosing strategies and research into higher doses, genetic variability, and hormonal influences. Future studies should integrate biomechanical metrics and controlled hormonal assessments to elucidate caffeine's nuanced role in anaerobic power sports.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.